New Genetic Insights Offer Hope for Non-Addictive Pain Relief
Researchers are developing a new non-addictive pain relief drug targeting specific neurons in the amygdala, supported by a $12 million NIH grant, aiming to treat chronic pain without the risks associated with opioids.